Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples